A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata

Apremilast lejos de ser una opción en alopecia areta😕 - "A randomized placebo-controlled single-center pilot study of apremilast in subjects with moderate-to-severe #alopecia #areata." https://t.co/FTmjRxk4BL #dermatología #tricoHRC #tricología